$6.70
0.45% yesterday
Nasdaq, May 20, 09:48 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Stock price

$6.69
+0.25 3.88% 1M
-1.29 16.17% 6M
-0.75 10.08% YTD
+1.75 35.43% 1Y
-7.98 54.40% 3Y
-18.84 73.80% 5Y
-18.84 73.80% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.04 0.59%
ISIN
US89455T1097
Symbol
TMCI
Sector

Key metrics

Market capitalization $420.83m
Enterprise Value $414.10m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.96
P/S ratio (TTM) P/S ratio 2.00
P/B ratio (TTM) P/B ratio 3.99
Revenue growth (TTM) Revenue growth 7.54%
Revenue (TTM) Revenue $210.82m
EBIT (operating result TTM) EBIT $-52.30m
Free Cash Flow (TTM) Free Cash Flow $-36.96m
Cash position $76.09m
EPS (TTM) EPS $-0.85
P/E forward negative
P/S forward 1.85
EV/Sales forward 1.82
Short interest 5.10%
Show more

Is Treace Medical Concepts Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Treace Medical Concepts Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Treace Medical Concepts Inc forecast:

2x Buy
29%
5x Hold
71%

Analyst Opinions

7 Analysts have issued a Treace Medical Concepts Inc forecast:

Buy
29%
Hold
71%

Financial data from Treace Medical Concepts Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
211 211
8% 8%
100%
- Direct Costs 42 42
12% 12%
20%
169 169
7% 7%
80%
- Selling and Administrative Expenses 192 192
0% 0%
91%
- Research and Development Expense 21 21
21% 21%
10%
-43 -43
13% 13%
-21%
- Depreciation and Amortization 8.97 8.97
29% 29%
4%
EBIT (Operating Income) EBIT -52 -52
8% 8%
-25%
Net Profit -53 -53
3% 3%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about Treace Medical Concepts Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Treace Medical Concepts Inc Stock News

Neutral
PRNewsWire
one day ago
NEW YORK , May 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. So what: If you purchased Treace Medical securities during the Class Period you may ...
Neutral
PRNewsWire
one day ago
NEW YORK , May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Neutral
GlobeNewsWire
one day ago
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
More Treace Medical Concepts Inc News

Company Profile

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Head office United States
CEO John Treace
Employees 477
Founded 2013
Website www.treace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today